Cofetuzumab Biosimilar - Anti-CCK4 Antibody - Low endotoxin, Azide free (A323366)

Cofetuzumab Biosimilar - Anti-CCK4 Antibody - Low endotoxin, Azide free

Recombinant humanized monoclonal antibody to CCK4.

ELISA, FACS, Functional Assay, In Vivo

Human, Mouse, Cynomolgus Macaque

Humanized

Monoclonal

IgG1

kappa

Unconjugated

Protein A affinity chromatography.

Reconstitution dependent.

> 95% (by SDS-PAGE and SEC-HPLC).

Lyophilized

Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!

Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.

Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.

8430404F20Rik, CCK 4, CCK-4, Colon carcinoma kinase 4, Human colon carcinoma kinase 4 (CCK4) mRNA complete cds, Inactive tyrosine-protein kinase 7, mPTK7/CCK4, OTTHUMP00000217016, Protein tyrosine kinase PTK 7, Protein-tyrosine kinase 7, Pseudo tyrosine kinase receptor 7, PTK 7, PTK7, PTK7 protein tyrosine kinase, PTK7 protein tyrosine kinase 7, PTK7_HUMAN, Serum response factor, Srf, Tyrosine-protein kinase-like 7